Donald Parsons

Professor

Baylor College of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Research Cancer Research professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Donald Parsons is a Professor at Baylor College of Medicine in the United States. His research focuses on pediatric oncology, particularly in the areas of genetic alterations in tumors and innovative treatment strategies for childhood cancers. Recent articles authored by Dr. Parsons include studies on hyperleukocytosis in neuroblastoma, central nervous system tumors with NTRK gene fusions, and the effectiveness of various therapies in pediatric populations.

Articles (20)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Sharon E. Plon

Baylor College of Medicine

UNITED STATES

View details

Xin Xu

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Ana S. Guerreiro Stucklin

University of Zurich

SWITZERLAND

View details

Frank Lin

Baylor College of Medicine Department of Pediatrics

UNITED STATES

View details

Holly Lindsay

Associate Professor

University of Colorado Health

UNITED STATES

View details

Chantel Cacciotti

Western University

CANADA

View details

Sinchita Roy‐Chowdhuri

UNITED STATES

View details

Ross Mangum

UNITED STATES

View details

Andrea T. Franson

UNITED STATES

View details

Sarah Scollon

Assistant Professsor/Genetic Counselor

Baylor College of Medicine

UNITED STATES

View details

Thinh Quoc Nguyen

Thomas Jefferson University

UNITED STATES

View details

Kevin E. Fisher

Baylor College of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Donald Parsons

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15

Clinical characteristics and outcome of central nervous system tumors harboring NTRK gene fusions.

Comparing the Diagnostic Yield of Germline Exome Versus Panel Sequencing in the Diverse Population of the Texas KidsCanSeq Pediatric Cancer Study.

Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I).

Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D.

Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.

Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial.

Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer.

Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.

Recent Advancements and Innovations in Pediatric Precision Oncology.

Tazemetostat for Tumors Harboring SMARCB1/SMARCA4 or EZH2 Alterations: Results from NCI-COG Pediatric MATCH APEC1621C.

Views of Adolescents and Young Adults with Cancer and Their Oncologists Toward Patients' Participation in Genomic Research.

The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.

Epigenetic Alterations of Repeated Relapses in Patient-matched Childhood Ependymomas.

Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial

Clinical and molecular features of pediatric cancer patients with Lynch syndrome.

A Validation Framework for Somatic Copy Number Detection in Targeted Sequencing Panels.

Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.

Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma.

TRK-inhibition for pediatric and adult central nervous system tumors: Early promise and future questions.

Collaborators (12)

Sharon E. Plon

Xin Xu

Ana S. Guerreiro Stucklin

Frank Lin

Holly Lindsay

Chantel Cacciotti

Sinchita Roy‐Chowdhuri

Ross Mangum

Andrea T. Franson

Sarah Scollon

Thinh Quoc Nguyen

Kevin E. Fisher

Make your next move.